home / stock / clrb / clrb news

CLRB News and Press, Cellectar Biosciences Inc. From 12/26/23

Stock Information
Company Name: Cellectar Biosciences Inc.
Stock Symbol: CLRB
Market: NASDAQ
Website: cellectar.com
Menu
CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
Get CLRB Alerts

News, Short Squeeze, Breakout and More Instantly...
CLRB - LI, SSYS and ATNM among pre-market gainers

2023-12-26 08:22:28 ET Gainers: RayzeBio ( RYZB ) +100% on being acquired by Bristol Myers Squibb . Gracell Biotechnologies ( GRCL ) +60% to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases . IMAC Holdings ( BA...
CLRB - Cellectar Biosciences Expands Iopofosine I 131 Collaboration with Wisconsin Alumni Research Foundation

FLORHAM PARK, N.J., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced a new licensing agreement with the Wi...

CLRB - Cellectar Biosciences Strengthens Intellectual Property Protection for its PDC Platform

FLORHAM PARK, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that is has received Notice of Allowa...

CLRB - Cellectar Biosciences to Present at the Targeted Radiopharmaceuticals Summit Europe

FLORHAM PARK, N.J., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that Jarrod Longcor, Cellectar’...
CLRB - Cellectar Biosciences, Inc. (CLRB) Q3 2023 Earnings Call Transcript

2023-11-02 14:19:05 ET Cellectar Biosciences, Inc. (CLRB) Q3 2023 Earnings Conference Call November 02, 2023, 08:30 ET Company Participants Monique Kosse - LifeSci Advisors James Caruso - CEO Chad Kolean - CFO Shane Lea - CCO Andrei Shustov - SVP, Medical...

CLRB - Cellectar to Release Top-line Data from WM Pivotal Trial During the JP Morgan Healthcare Conference the Week of January 8, 2024

Reports Preliminary Financial Results for Third Quarter 2023 and Provides a Corporate Update Conference Call scheduled for today at 8:30 am Eastern Time FLORHAM PARK, N.J., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical bio...

CLRB - Expected US Company Earnings on Thursday, November 2nd, 2023

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
CLRB - Expected earnings - Cellectar Biosciences Inc.

Cellectar Biosciences Inc. (CLRB) is expected to report $-0.44 for Q3 2023

CLRB - Cellectar Biosciences Q3 2023 Earnings Preview

2023-11-01 14:15:25 ET More on Cellectar Biosciences Seeking Alpha’s Quant Rating on Cellectar Biosciences Historical earnings data for Cellectar Biosciences Financial information for Cellectar Biosciences For further details see: Cellectar Bioscie...

CLRB - Notable earnings before Thursday's open

2023-11-01 11:48:22 ET Major earnings expected before the bell on Thursday include: Barrick Gold ( GOLD ) Moderna ( MRNA ) Palantir Technologies ( PLTR ) Starbucks ( SBUX ) Shopify ( SHOP ) For further details see: Notable earnings before ...
Previous 10 Next 10